NO20051794D0 - Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike - Google Patents

Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike

Info

Publication number: NO20051794D0
Authority: NO; Norway
Prior art keywords: preparation; processes; novel intermediates; epothilone derivatives; epothilone
Prior art date: 2002-09-13

Application number

NO20051794A

Other languages

English (en)

Norwegian (no)

Other versions

NO20051794L (no

Inventor

Olivier Loiseleur

Guido Koch

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-13

Filing date

2005-04-12

Publication date

2005-04-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9944042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051794(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-04-12 Application filed by Novartis Ag filed Critical Novartis Ag

2005-04-12 Publication of NO20051794L publication Critical patent/NO20051794L/no

2005-04-12 Publication of NO20051794D0 publication Critical patent/NO20051794D0/no

Links

238000000034 method Methods 0.000 title 3
150000003883 epothilone derivatives Chemical class 0.000 title 1
239000000543 intermediate Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)

NO20051794A 2002-09-13 2005-04-12 Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike NO20051794D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0221312.2A GB0221312D0 (en)	2002-09-13	2002-09-13	Organic compounds
PCT/EP2003/010171 WO2004024735A2 (en)	2002-09-13	2003-09-12	A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same

Publications (2)

Publication Number	Publication Date
NO20051794L NO20051794L (no)	2005-04-12
NO20051794D0 true NO20051794D0 (no)	2005-04-12

Family

ID=9944042

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20051794A NO20051794D0 (no)	2002-09-13	2005-04-12	Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike

Country Status (29)

Country	Link
US (1)	US7470792B2 (es)
EP (1)	EP1539768B1 (es)
JP (1)	JP4628102B2 (es)
KR (1)	KR20050042500A (es)
CN (1)	CN100522968C (es)
AR (1)	AR041231A1 (es)
AT (1)	ATE373663T1 (es)
AU (2)	AU2003267349B2 (es)
BR (1)	BR0314263A (es)
CA (1)	CA2497119C (es)
CY (1)	CY1107794T1 (es)
DE (1)	DE60316456T2 (es)
DK (1)	DK1539768T3 (es)
EC (1)	ECSP055652A (es)
ES (1)	ES2290489T3 (es)
GB (1)	GB0221312D0 (es)
IL (1)	IL166829A (es)
MX (1)	MXPA05002785A (es)
MY (1)	MY140442A (es)
NO (1)	NO20051794D0 (es)
NZ (1)	NZ538612A (es)
PE (1)	PE20050052A1 (es)
PL (1)	PL375039A1 (es)
PT (1)	PT1539768E (es)
RU (2)	RU2404985C2 (es)
SG (1)	SG155770A1 (es)
TW (1)	TWI289563B (es)
WO (1)	WO2004024735A2 (es)
ZA (1)	ZA200501008B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2273083C (en)	1996-12-03	2012-09-18	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US7649006B2 (en)	2002-08-23	2010-01-19	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto and analogues thereof
US6921769B2 (en)	2002-08-23	2005-07-26	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto and analogues thereof
EP2186811A1 (en)	2002-08-23	2010-05-19	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US20110300150A1 (en)	2010-05-18	2011-12-08	Scott Eliasof	Compositions and methods for treatment of autoimmune and other disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU716610B2 (en) *	1996-08-30	2000-03-02	Novartis Ag	Method for producing epothilones, and intermediate products obtained during the production process
US6380394B1 (en) *	1996-12-13	2002-04-30	The Scripps Research Institute	Epothilone analogs
US6441186B1 (en) *	1996-12-13	2002-08-27	The Scripps Research Institute	Epothilone analogs
JP2001513098A (ja) *	1997-02-25	2001-08-28	ゲゼルシャフトフュアバイオテクノロギッシェフォーシュンクエムベーハー（ゲーベーエフ）	側鎖を修飾したエポチロン
US6498257B1 (en) *	1998-04-21	2002-12-24	Bristol-Myers Squibb Company	2,3-olefinic epothilone derivatives
GB9810659D0 (en) *	1998-05-18	1998-07-15	Ciba Geigy Ag	Organic compounds
PT1140944E (pt) *	1998-12-22	2004-01-30	Novartis Pharma Gmbh	Derivados de epotilona e sua utilizacao como agentes antitumorais
EP1226142A2 (en) *	1999-07-22	2002-07-31	Schering Aktiengesellschaft	Process for the production of epothiolone b and derivatives as well as intermediate products for this process
US6593115B2 (en) *	2000-03-24	2003-07-15	Bristol-Myers Squibb Co.	Preparation of epothilone intermediates
IL155306A0 (en)	2000-10-13	2003-11-23	Univ Mississippi	Methods for producing epothilone derivatives and analogs and epothilone derivatives and analogs produced thereby
BR0313043A (pt)	2002-07-31	2005-06-14	Schering Ag	Conjugados efetores, processo para sua produção e seu uso farmacêutico

2002
- 2002-09-13 GB GBGB0221312.2A patent/GB0221312D0/en not_active Ceased
2003
- 2003-09-11 AR ARP030103290A patent/AR041231A1/es active IP Right Grant
- 2003-09-11 PE PE2003000922A patent/PE20050052A1/es not_active Application Discontinuation
- 2003-09-12 NZ NZ538612A patent/NZ538612A/en not_active IP Right Cessation
- 2003-09-12 DE DE60316456T patent/DE60316456T2/de not_active Expired - Lifetime
- 2003-09-12 PL PL03375039A patent/PL375039A1/xx not_active Application Discontinuation
- 2003-09-12 PT PT03748015T patent/PT1539768E/pt unknown
- 2003-09-12 JP JP2004535499A patent/JP4628102B2/ja not_active Expired - Fee Related
- 2003-09-12 DK DK03748015T patent/DK1539768T3/da active
- 2003-09-12 TW TW092125250A patent/TWI289563B/zh not_active IP Right Cessation
- 2003-09-12 CN CNB038215837A patent/CN100522968C/zh not_active Expired - Fee Related
- 2003-09-12 EP EP03748015A patent/EP1539768B1/en not_active Expired - Lifetime
- 2003-09-12 AT AT03748015T patent/ATE373663T1/de active
- 2003-09-12 MX MXPA05002785A patent/MXPA05002785A/es active IP Right Grant
- 2003-09-12 US US10/526,283 patent/US7470792B2/en not_active Expired - Fee Related
- 2003-09-12 WO PCT/EP2003/010171 patent/WO2004024735A2/en not_active Ceased
- 2003-09-12 RU RU2008129613/04A patent/RU2404985C2/ru not_active IP Right Cessation
- 2003-09-12 SG SG200701814-6A patent/SG155770A1/en unknown
- 2003-09-12 RU RU2005110925/04A patent/RU2343155C2/ru not_active IP Right Cessation
- 2003-09-12 ES ES03748015T patent/ES2290489T3/es not_active Expired - Lifetime
- 2003-09-12 AU AU2003267349A patent/AU2003267349B2/en not_active Ceased
- 2003-09-12 KR KR1020057004237A patent/KR20050042500A/ko not_active Ceased
- 2003-09-12 BR BR0314263-9A patent/BR0314263A/pt not_active IP Right Cessation
- 2003-09-12 CA CA2497119A patent/CA2497119C/en not_active Expired - Fee Related
- 2003-09-13 MY MYPI20033494A patent/MY140442A/en unknown
2005
- 2005-02-03 ZA ZA200501008A patent/ZA200501008B/xx unknown
- 2005-02-10 IL IL166829A patent/IL166829A/en not_active IP Right Cessation
- 2005-03-09 EC EC2005005652A patent/ECSP055652A/es unknown
- 2005-04-12 NO NO20051794A patent/NO20051794D0/no not_active Application Discontinuation
2007
- 2007-11-08 CY CY20071101447T patent/CY1107794T1/el unknown
2008
- 2008-08-01 AU AU2008203451A patent/AU2008203451A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20060106073A1 (en)	2006-05-18
IL166829A (en)	2011-01-31
PT1539768E (pt)	2007-12-17
PL375039A1 (en)	2005-11-14
WO2004024735A2 (en)	2004-03-25
CN100522968C (zh)	2009-08-05
WO2004024735A3 (en)	2004-07-22
NZ538612A (en)	2008-01-31
US7470792B2 (en)	2008-12-30
MXPA05002785A (es)	2005-06-03
DK1539768T3 (da)	2008-01-07
SG155770A1 (en)	2009-10-29
RU2343155C2 (ru)	2009-01-10
AR041231A1 (es)	2005-05-11
GB0221312D0 (en)	2002-10-23
AU2008203451A1 (en)	2008-08-21
EP1539768B1 (en)	2007-09-19
CN1681824A (zh)	2005-10-12
ZA200501008B (en)	2006-12-27
PE20050052A1 (es)	2005-03-28
BR0314263A (pt)	2005-07-05
CY1107794T1 (el)	2013-06-19
MY140442A (en)	2009-12-31
NO20051794L (no)	2005-04-12
ECSP055652A (es)	2005-05-30
JP4628102B2 (ja)	2011-02-09
RU2005110925A (ru)	2006-01-20
ATE373663T1 (de)	2007-10-15
ES2290489T3 (es)	2008-02-16
HK1078853A1 (en)	2006-03-24
JP2006511469A (ja)	2006-04-06
KR20050042500A (ko)	2005-05-09
CA2497119A1 (en)	2004-03-25
AU2003267349B2 (en)	2008-05-01
EP1539768A2 (en)	2005-06-15
DE60316456D1 (de)	2007-10-31
TW200413388A (en)	2004-08-01
CA2497119C (en)	2011-08-02
RU2008129613A (ru)	2010-01-27
TWI289563B (en)	2007-11-11
DE60316456T2 (de)	2008-06-19
RU2404985C2 (ru)	2010-11-27
AU2003267349A1 (en)	2004-04-30

Legal Events

Date	Code	Title	Description
2012-05-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
PT1398327E (pt)	2008-10-31	Método de produção de derivados de hidroxialquil-amido
NO20015156D0 (no)	2001-10-22	5-pyridyl-1,3-Azol forbindelser, fremgangsmåte for produksjon av de samme og deres anvendelse
NO20043345L (no)	2004-08-11	Fremgangsmate for fremstilling av hydrokarboner
NO20040933L (no)	2004-03-03	Nye gamma-sekretaseinhibitorer.
NO20053115D0 (no)	2005-06-24	Fremgangsmate for fremstilling av 2'-forgrenede nukleosider.
NO20032425D0 (no)	2003-05-28	Nye krystallformer av atorvastatin-hemi-kalsium og fremgangsmåter for deresfremstilling, samt nye fremgangsmåter for fremstilling av andreformer
IL173289A0 (en)	2006-06-11	Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
IS7768A (is)	2005-03-22	Aðferðir til framleiðslu, einangrunar og hreinsunar epóþílóns B, og röntgengeisla kristallabyggingar epóþílóns B
NO20051503D0 (no)	2005-03-21	Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
NO20043586L (no)	2004-10-07	Fremgangsmate for fremstilling av organiske forbindelser
NO20043842L (no)	2004-09-14	Nye krystallformer av atorvastatinhemikalsium og fremgangsmater for fremstilling derav, savel som nye fremgangsmater for fremstilling av atorvastatinhemikalsiumform I, VIII og IX
FR2846964B1 (fr)	2006-07-21	Procede de fabrication de 1,2-epoxy-3-chloropropane
NO20044814L (no)	2004-01-07	Fremgangsmate for fremstilling av combretastaniner
NO20051794D0 (no)	2005-04-12	Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike
NO20060184L (no)	2006-03-13	Fremgangsmate for fremstilling av ikke-peptid substituerte spirobenzoazepinderivater
NO20052859D0 (no)	2005-06-13	Fremgangsmate for fremstilling av resperidon og intermediater derav
NO20052471D0 (no)	2005-05-23	Fremgangsmate for fremstilling av 3-metyltiopropanal.
NO20034597D0 (no)	2003-10-14	Fremgangsmåte for fremstilling av cantaxantin
DK1511724T3 (da)	2014-06-16	Fremgangsmåde til fremstilling af thioalkylaminderivater
NO20020308L (no)	2002-03-21	Fremgangsmåte for fremstilling av epotilon B og derivater derav samt mellomprodukter for fremgangsmåten
PH12005500143B1 (en)	2011-03-25	Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
DK1513833T3 (da)	2006-08-21	Nye forbindelser af 3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-on, fremgangsmåde til fremstilling af samme samt farmaceutiske sammensætninger indeholdende samme
ITMI20031670A1 (it)	2005-02-27	Processo per la preparazione di cilostazolo e di suoi intermedi.
AU2003264822A1 (en)	2004-05-04	Epothilone derivatives for the treatment of multiple myeloma
ITTO20020081A1 (it)	2003-07-29	Apparato e metodo per la produzione di filato.